Gheorghe Doros, PhD
Boston University School of Public Health
Dept of Biostatistics

PhD, Yale University
MA, Yale University
MS, University of Bucharest

Gheorghe Doros is Professor of Biostatistics and director of the Biostatistics Consulting Group. He received his PhD in Statistics from Yale University and joined BUSPH’s Department of Biostatistics in 2006 after spending two years at Eli Lilly, as a member of that company's Drug Discovery and Toxicology department. Dr. Doros’s research on methodological approaches and strategies has been concentrated in the area of clinical trials, more specifically on Bayesian approaches to clinical trials and the area of placebo response in clinical trials. The outcome of his work has been a corner stone in developing a host of collaborations with outstanding faculty, clinicians, and researchers at the Boston University Medical Campus and at other institutions. These productive collaborations have resulted in several federally funded grants. Dr. Doros authored and co-authored many peer-reviewed publications of original and innovative research which has had a major impact on the field. On the majority of publications, Dr. Doros is the lead statistician author. He demonstrated continuing record of multidisciplinary research that has had a major impact on the rapidly changing field. His publications on clinical trials; most proposing the design, analysis and new methodologies or of significant contributions to this field.

Dr. Doros is a very active and effective teacher and mentor in the department of Biostatistics. His teaching philosophy is to pursue an active approach to learning and to engage students to think critically. He taught core and elective courses for Master and PhD-level courses. The excellent course evaluations he received attests to his ability in engaging students in active learning. Dr. Doros has been awarded the excellence in teaching three times in three years.

On a national level, Dr. Doros has served as an Associate Editor for the BioMed Central’s journal Trials and as a reviewer for a number of academic journals. He served as a member of the merit review subcommittee for Epidemiology of the Department of Veteran Affairs and a member NHLBI-Ancillary Studies in Clinical Trials between 2012 and 2014. He has served as a statistical expert on a number of Independent Data Monitoring Committee(IDMC) for clinical trials and clinical programs. He served or seves as a senior consultant on multicenter trials and/or programs for the following organizations Pfizer, Takeda, Avanir, Sarepta and Children's Hospital.

Boston University
BU-BMC Cancer Center

Boston Medical Center

2008-2010 Boston University School of Public Health: Excellence in Teaching Award

VA241-16-D-0012 VA Master Contract Task Order 24
09/01/2020 - 08/31/2021 (PI)
VA Boston Healthcare System

VA241-16-D-0012 VA Master Contract Task Order 19
05/01/2020 - 08/31/2021 (PI)
VA Boston Healthcare System

Gheorghe Doros, PhD: Statistical research in clinical trials (Baim Institute for Clinical Research)
09/01/2017 - 08/31/2021 (PI)
Baim Institute for Clinical Research

VA241-16-D-0012 VA Master Contract Task Order 18
09/01/2019 - 08/31/2020 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
05/01/2016 - 08/31/2019 (PI)
VA Boston Healthcare System

Gheorghe Doros, PhD (faculty): Statistical research in clinical trials (Harvard Clinical Research Institute)
09/01/2016 - 08/31/2017 (PI)
Harvard Clinical Research Institute

Personnel Agreement for Research Services of Gheorghe Doros
06/01/2012 - 02/28/2016 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
07/01/2012 - 05/31/2013 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
08/01/2009 - 03/31/2012 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
06/01/2008 - 03/31/2012 (PI)
VA Boston Healthcare System

Showing 10 of 11 results. Show All Results


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Garcia MA, Rampon GL, Doros G, Jia S, Jagan N, Gillmeyer K, Berical A, Hudspeth J, Ieong M, Modzelewski KL, Schechter-Perkins EM, Ross CS, Rucci JM, Simpson S, Walkey AJ, Bosch NA. Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 Study Protocol: A Clinical Trial. Ann Am Thorac Soc. 2021 09; 18(9):1560-1566.View Related Profiles. PMID: 33647225
  2. Kuku KO, Garcia-Garcia HM, Doros G, Mintz GS, Ali ZA, Skinner WH, Artis AK, Ten Cate T, Powers E, Wong SC, Wykrzykowska J, Dube S, Kazziha S, van der Ent M, Shah P, Sum S, Torguson R, Di Mario C, Waksman R. Predicting future left anterior descending artery events from non-culprit lesions: insights from the Lipid-Rich Plaque study. Eur Heart J Cardiovasc Imaging. 2021 Aug 19. PMID: 34410335
  3. Bambagioni G, Di Mario C, Torguson R, Demola P, Ali Z, Singh V, Skinner W, Artis A, Cate TT, Zhang C, Garcia-Garcia HM, Doros G, Mintz GS, Waksman R. Lipid-rich plaques detected by near-infrared spectroscopy predict coronary events irrespective of age: A Lipid Rich Plaque sub-study. Atherosclerosis. 2021 Aug 14; 334:17-22. PMID: 34455112
  4. Kereiakes DJ, Feldman RL, Ijsselmuiden AJJ, Saito S, Amoroso G, Zidar JP, Wong SC, Stella P, Yakubov S, Lasala J, Cohen DJ, Doros G, Cutlip DE, Rao SV. Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study. Circ Cardiovasc Interv. 2021 Aug 06; CIRCINTERVENTIONS121010609. PMID: 34353122
  5. Staron A, Zheng L, Doros G, Connors LH, Mendelson LM, Joshi T, Sanchorawala V. Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study. Blood Cancer J. 2021 Aug 04; 11(8):139.View Related Profiles. PMID: 34349108; PMCID: PMC8338947; DOI: 10.1038/s41408-021-00529-w;
  6. Hsu JC, Reynolds MR, Song Y, Doros G, Lubitz SA, Gehi AK, Turakhia MP, Maddox TM. Outpatient Prescription Practices in Patients with Atrial Fibrillation (From the NCDR PINNACLE Registry). Am J Cardiol. 2021 Sep 15; 155:32-39. PMID: 34284863
  7. Medranda GA, Zhang C, Doros G, Yerasi C, Case BC, Weintraub WS, Waksman R. Meta-Analysis of Usefulness of Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack. Am J Cardiol. 2021 Aug 15; 153:129-134. PMID: 34226040
  8. Medranda GA, Rogers T, Doros G, Zhang C, Case BC, Yerasi C, Shults CC, Waksman R. Transcatheter aortic valve replacement in low-risk bicuspid and tricuspid patients: Meta-analysis. Cardiovasc Revasc Med. 2021 Jun 25. PMID: 34253474
  9. Nader R, Zhen A, Angel-Korman A, Pavlovich SS, Pogrebinsky A, Doros G, Menn-Josephy H, Stern L, Sanchorawala V, Havasi A. Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis. Nephrol Dial Transplant. 2021 May 27.View Related Profiles. PMID: 34043009
  10. Rogers T, Medranda GA, Doros G, Weintraub WS, Waksman R. TAV-in-TAV Versus TAV-in-SAV: A Troublesome Analysis and the Wrong Question. J Am Coll Cardiol. 2021 May 18; 77(19):2450-2451. PMID: 33985690
Showing 10 of 318 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 318 publications over 19 distinct years, with a maximum of 41 publications in 2014

Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Doros's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department